Amgen Announces Voting Results of Annual Meeting of Stockholders

Posted: May 23rd, 2013  |  Company/topic: Amgen
Website: BioSpace.com Featured News
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!THOUSAND OAKS, Calif., May 22, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced voting results from..
Tags: , ,

Amgen and Zhejiang Beta Pharma announce planned joint venture in China

Posted: May 10th, 2013  |  Company/topic: Amgen
Website: Breaking World Pharma News
Amgen (NASDAQ:AMGN) and Zhejiang Beta Pharma Co., Ltd. (Zhejiang Beta Pharma) today announced that the companies have signed an agreement to form a joint venture to commercialize Amgen's Vectibix®…
Tags: , ,

Amgen blood drugs may help humans survive nuclear attack, FDA says

Posted: May 1st, 2013  |  Company/topic: Amgen
Website: FiercePharma News
Here's a story that takes us back to our Cold War childhood. Two of Amgen's ($AMGN) blockbuster blood drugs, Neulasta and Neupogen, may help victims survive after a nuclear attack, FDA staff reviewers…
Tags: , ,

Amgen’s First Quarter 2013 Revenues Increased 5 Percent to $4.2 Billion and Adjusted Earnings Per Share (EPS) Increased 22 Percent to $1.96

Posted: April 24th, 2013  |  Company/topic: Amgen
Website: BioSpace.com Featured News
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!THOUSAND OAKS, Calif., April 23, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results f…
Tags: , ,